切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 539 -543. doi: 10.3877/cma.j.issn.2095-3232.2021.06.001

述评

肝叶增生促进技术在剩余肝体积不足肝切除中的应用
曹磊1, 廖明恒1, 曾勇1,()   
  1. 1. 610041 成都,四川大学华西医院肝脏外科及肝移植中心
  • 收稿日期:2021-09-02 出版日期:2021-09-23
  • 通信作者: 曾勇

Liver regeneration inducing techniques in hepatectomy with insufficient future liver remnant

Lei Cao1, Mingheng Liao1, Yong Zeng1()   

  • Received:2021-09-02 Published:2021-09-23
  • Corresponding author: Yong Zeng
引用本文:

曹磊, 廖明恒, 曾勇. 肝叶增生促进技术在剩余肝体积不足肝切除中的应用[J]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 539-543.

Lei Cao, Mingheng Liao, Yong Zeng. Liver regeneration inducing techniques in hepatectomy with insufficient future liver remnant[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(06): 539-543.

[1]
Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria[J]. Br J Surg, 2012, 99(12):1622-1629.
[2]
Stiles Zachary E, Behrman Stephen W, Glazer Evan S, et al. Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database[J]. HPB, 2017, 19(11):957-965.
[3]
Kong Z, Hu J, Ge X, et al. Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy[J]. Exp Ther Med, 2018, 16(3):1910-1918.
[4]
Shindoh J, Tzeng CWD, Vauthey J. Portal vein embolization for hepatocellular carcinoma[J]. Liver Cancer, 2012, 1(3/4): 159-167.
[5]
Aoki T, Kubota K. Preoperative portal vein embolization for hepatocellular carcinoma: consensus and controversy[J]. World J Hepatology, 2016, 8(9):439-445.
[6]
Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant[J]. J Gastrointestinal Surg, 2008, 12(2):297-303.
[7]
Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases[J]. Arch Surg, 2008, 143(10):978-982.
[8]
Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy:a planned strategy to treat irresectable liver tumors[J]. Ann Surg, 2000, 232(6):777-785.
[9]
Imai K, Allard M, Benitez C, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?[J]. Oncologist, 2016, 21(7):887-894.
[10]
de Santibañes E, Clavien P. Playing play-doh to prevent postoperative liver failure: the "ALPPS" approach[J]. Ann Surg, 2012, 255(3):415-417.
[11]
Schnitzbauer Andreas A, Lang Sven A, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[12]
Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? a single-center experience[J]. Ann Surg, 2015, 261(4): e90-92.
[13]
de Santibañes E, Alvarez FA, Ardiles V, et al. Inverting the ALPPS paradigm by minimizing first stage impact: the mini-ALPPS technique[J]. Langenbecks Arch Surg, 2016, 401(4):557-563.
[14]
Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure[J]. Br J Surg, 2014, 101(9):1129-1134.
[15]
Gringeri E, Boetto R, D'Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach[J]. Ann Surg, 2015, 261(2): 42-43.
[16]
Gall TMH, Sodergren MH, Frampton AE, et al. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration[J]. Ann Surg, 2015, 261(2):45-46.
[17]
Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy[J]. Ann Surg, 2009, 249(4):608-616.
[18]
Hwang S, Ha TY, Ko GY, et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy[J]. World J Surg, 2015, 39(12):2990-2998.
[19]
Munene G, Parker RD, Larrigan J, et al. Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases[J]. World J Surg Oncol, 2013(11):134.
[20]
Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique[J]. Eur Radiol, 2016, 26(12): 4259-4267.
[21]
Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg, 2006, 93(9):1091-1098.
[22]
Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection[J]. Br J Surg, 2013, 100(3):388-394.
[23]
Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach[J]. J Am Coll Surg, 2013, 217(1):126-133.
[24]
Croome KP, Hernandez-Alejandro R, Parker M, et al. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? a multicentre analysis[J]. HPB, 2015, 17(6):477-484.
[25]
Schadde E, Hernandez-Alejandro R, Lang H, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors. results of a multicentre analysis: reply[J]. World J Surg, 2015, 39(7):1510-1519.
[26]
Tanaka K, Matsuo K, Murakami T, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity[J]. European J Surg Oncol, 2015, 41(4):506-512.
[27]
Ratti F, Schadde E, Masetti M, et al. Strategies to increase resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS versus conventional two-stage hepatectomy[J]. Ann Surg Oncol, 2015, 22(6):1933-1942.
[28]
Matsuo K, Murakami T, Kawaguchi D, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization[J]. Surgery, 2016, 159(5):1289-1298.
[29]
Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection[J]. Gut, 2005, 54(2):289-296.
[30]
崔宏,高琴琴,王效益, 等. 肝细胞癌合并肝硬化患者肝切除术后标准残肝体积评估[J]. 中国现代普通外科进展, 2019, 22(4):296-299.
[31]
Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver[J]. J Am Coll Surg, 2007, 204(1):22-33.
[32]
Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry[J]. Ann Surg, 2009, 250(4):540-548.
[33]
李富贵,严律南,曾勇, 等. 中国成人标准肝体积评估公式的临床研究[J]. 四川大学学报(医学版), 2009, 40(2):302-306.
[34]
陈熙,杜正贵,李波, 等. 标准残肝体积对肝脏储备功能的评价[J]. 世界华人消化杂志, 2010, 18(17):1829-1833.
[35]
Kamiyama T, Kakisaka T, Orimo T, et al. Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus[J]. World J Hepatol, 2017, 9(36):1296-1304.
[36]
Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of45 patients[J]. Ann Surg, 2020, 271(3):534-541.
[37]
李健,文张,徐邦浩,等. 联合门静脉切除重建的ALPPS治疗肝内胆管细胞癌[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(1):62-66.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[5] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[6] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[7] 刘波, 涂志坚, 李传富, 李江涛, 陈国栋. 机器人解剖性左半肝切除术[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 486-486.
[8] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[9] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[10] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[11] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[12] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[13] 张立鑫, 朱建交, 李敬东. 机器人肝切除技术的优势与劣势[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 477-479.
[14] 韩冰, 顾劲扬. 深度学习神经网络在肝癌诊疗中的研究及应用前景[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 480-485.
[15] 何传超, 肖治宇. 晚期肝癌综合治疗模式与策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 486-489.
阅读次数
全文


摘要